Approximately 60% of women will experience a UTI in their lifetime2 — Flush Advanced+ helps to reduce the risk of recurrent ...

Locus Biosciences today announced a contract award from the National Institute of Allergy and Infectious Diseases (NIAID), ...

Service expansions accelerate pharmacy’s achievement of 2 million shipments while maintaining industry-leading patient ...

Arcus’s highest priority is to execute on its ongoing Phase 3 trial and overall development plan aimed at establishing casdatifan as the standard-of-care and backbone therapy for clear cell renal cell ...

Veteran trial lawyer among 102 attorneys honored nationwide for 2026HOUSTON--(BUSINESS WIRE)--Iconic Houston trial lawyer Mark Lanier has been inducted into the Lawdragon Hall of Fame class of ...

Exclusive agreement covers 13 Central and Eastern European marketsCollaboration will help expand access to VANFLYTA for ...

Number of Lawsuits Increases Fivefold to Over 2,100 Since May- FDA Approves Brain Tumour WarningGlobal pharmaceutical company Pfizer Inc. (NYSE: PFE), manufacturer of contraceptive injection ...

U.S. IND represents the second regulatory clearance for KLN-1010 and enables the first multi-center clinical trial in the U.S ...

The integration aims to empower millions of users with deeper insights into migraine triggers through biometric ...

Bringing Decades of Successful Biotech Company Growth, Financing, IPO and M&A ExpertiseNORFOLK, Va.--(BUSINESS WIRE)--ReAlta ...

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...